Drug Trial Radar · NCT02724358
Rg3 in Combination With TACE in Hepatocellular Carcinoma Patients With High Expression of Notch1
Last checked: Nov 20, 2026Latest source record: Mar 31, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
320
Actual
Start
Dec 2012
Primary completion
Dec 2013
Study completion Dec 2015
Sponsor
- Lead sponsor
- Eastern Hepatobiliary Surgery HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Mar 31, 2016
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
In order to provide a new option for clinical anti-angiogenesis therapy in hepatoma, a randomized controlled study is planed to confirm the effect of Rg3 in combination with TACE on angiogenesis and tumor treatment in advanced hepatocellular carcinoma patients with high expression of Notch1.
Conditions
- Hepatocellular Carcinoma
- TACE
- Notch1
- Rg3
Interventions
TACEProcedure
iodized oil (5ml) + Pirarubicin (20mg)
Rg3Drug
20mg, BID, maintained though Month 12.
TACE + Rg3Other
protective therapyProcedure
standard liver protective therapy
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall SurvivalTime frame: 3 years
- Time to progressionTime frame: 3 years
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Eastern hepatobilliary surgery hospital
Shanghai, Shanghai Municipality, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.